Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (421-430 of 527) with videos related to

Pageof 53
Sort By:
The Kaohsiung Journal of Medical Sciences|July 12, 2025
Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLDChin-I Shih, Ming-Lun Yeh, Yi-Hung Lin, et al.
Clinical Kidney Journal|December 4, 2023
Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort studyChung-Feng Huang, Chia-Yen Dai, Chih-Wen Wang, et al.
Gut|December 11, 2020
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)Ming-Lung Yu, Chung-Feng Huang, Yu-Ju Wei, et al.
American Journal of Cancer Research|February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradicationMing-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology|April 5, 2020
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapyTyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, et al.
World Journal of Gastroenterology|February 7, 2022
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradicationMing-Ying Lu, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Viral Hepatitis|January 5, 2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2023
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational studyEiichi Ogawa, Dae Won Jun, Hidenori Toyoda, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analoguesTyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysisPo-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.
Pageof 53

Showing results (421-430 of 527) with videos related to

Sort By:
Pageof 53
The Kaohsiung Journal of Medical Sciences|July 12, 2025
Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLDChin-I Shih, Ming-Lun Yeh, Yi-Hung Lin, et al.
Clinical Kidney Journal|December 4, 2023
Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort studyChung-Feng Huang, Chia-Yen Dai, Chih-Wen Wang, et al.
Gut|December 11, 2020
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)Ming-Lung Yu, Chung-Feng Huang, Yu-Ju Wei, et al.
American Journal of Cancer Research|February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradicationMing-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology|April 5, 2020
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapyTyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, et al.
World Journal of Gastroenterology|February 7, 2022
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradicationMing-Ying Lu, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Viral Hepatitis|January 5, 2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2023
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational studyEiichi Ogawa, Dae Won Jun, Hidenori Toyoda, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analoguesTyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysisPo-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.
Pageof 53